Resumo

VILLA-GOMEZ, Cristian Camilo; VELILLA-AGUIRRE, Daniel Stiven; LOPERA-RESTREPO, Laura Camila  e  HOYOS-DUQUE, Sergio Iván. Primary Sclerosing Cholangitis. A narrative review. Iatreia [online]. 2020, vol.33, n.3, pp.251-261. ISSN 0121-0793.  https://doi.org/10.17533/udea.iatreia.57.

Primary sclerosing cholangitis (PSC) is a rare, chronic liver pathology characterized by inflammation and fibrosis of the bile ducts, whose evolution can lead to cirrhosis, portal hypertension and end-stage liver disease. Its etiology is unknown, but it has been related to genetic and autoinflammatory factors. In addition, it has a very close relationship with inflammatory bowel disease. Its clinical presentation is nonspecific, the main symptoms are pruritus and fatigue.

The standard test for diagnosis is magnetic resonance cholangiopancreatography (MRCP), where an annular aspect is observed caused by short multifocal stenoses with alternating normal or dilated segments. Currently, there is no pharmacological treatment that can prolong the survival without liver transplantation in PSC. Symptomatic treatment is warranted, especially for pruritus. The only curative treatment that is currently available is liver transplantation, although there is a risk of recurrence of the disease. The monitoring of intestinal inflammatory disorders (IID), malignancy and metabolic bone disease in these patients is very important. It has been seen that some factors, such as early diagnosis, are good prognosis for the disease.

Palavras-chave : Cholangiocarcinoma; Cholangitis, Sclerosing; Cholestasis; Colorectal Neoplasms; Liver Transplantation; Ulcerative Colitis.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )